Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.


TSXV:KNE - Post by User

Bullboard Posts
Post by TechnicalBuyon May 31, 2011 10:46am
296 Views
Post# 18649388

Army deal

Army dealHi folks. I've been recommending KNE.V in my alert svc since .07. My original post is here somewhere a few months back.

For those that are new to the story, you can find an in-depth look on www.technicalbuy.com. Here's a brief summary: Over the past 6 months Kane has progressed through several key milestones with their DispersinB product. Company is now preparing for a clinical trial of DispersinB. The results of the clinical trial should be available within a year or so. The money has been secured through the last round of financing.

In parallel to clinical trials, Kane has signed several collab agreements with the US Army, and several un-named pharamaceutical companies.

This monring's NR is a testament to the progress of the collaboration with the US Army. If successful, this research could yield a lucrative DispersinB order for Kane.

With several important efforts underway, Kane is an exciting play as this morning's pop can be replicated many times over in the next 12 months.

TB
technicalbuy.com
Bullboard Posts